AFT Pharmaceuticals Limited
AFT
Rank in Stocks
#15393
AFT Pharmaceuticals, along with its subsidiaries, focuses on the creation and... AFT Pharmaceuticals, along with its subsidiaries, focuses on the creation and distribution of pharmaceutical products across New Zealand, Australia, Asia, and other global markets. Their extensive product range addresses a variety of health categories, including but not limited to allergy relief, cold and flu remedies, digestive health, eye care, first aid essentials, nail and oral care, pain management, skincare solutions, and nutritional supplements. This company was established in 1997 and its main office is located in Auckland, New Zealand.
Share Price
$2.54
Last synced: 2026-11-10
Market Cap
$265.94M
Change (1 day)
0.00%
Change (1 year)
35.94%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade AFT Pharmaceuticals Limited (AFT)
Category
Healthcare
EPS for AFT Pharmaceuticals Limited (AFT)
EPS as of March 2026 TTM: $0.08
According to AFT Pharmaceuticals Limited's latest financial reports, its current EPS (TTM) is $0.08. At the end of 2025 the company had an EPS of $0.06, a decrease compared to its 2024 EPS of $0.09.
EPS history for AFT Pharmaceuticals Limited from 2013 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.08 | 31.17% |
| 2025 | $0.06 | -30.43% |
| 2024 | $0.09 | 43.29% |
| 2023 | $0.06 | -52.47% |
| 2022 | $0.13 | 156.73% |
| 2021 | $0.05 | -28.15% |
| 2020 | $0.07 | -520.00% |
| 2019 | $-0.02 | -81.95% |
| 2018 | $-0.09 | -29.28% |
| 2017 | $-0.13 | -55.23% |
| 2016 | $-0.30 | 121.35% |
| 2015 | $-0.13 | 933.85% |
| 2014 | $-0.01 | -784.21% |
| 2013 | 0.00 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $6.50 | 8,160.99% |
DE
|
|
| $6.08 | 7,622.49% |
DE
|
|
| $1.55 | 1,870.27% |
JP
|
|
| $3.66 | 4,550.57% |
CH
|
|
| $0.45 | 471.79% |
IL
|
Questions about AFT Pharmaceuticals Limited's earnings per share (EPS)
What is AFT Pharmaceuticals Limited's earnings per share (EPS)?
AFT Pharmaceuticals Limited's earnings per share (EPS) over the last twelve months is $0.08, as of Mar 2026.
What was AFT Pharmaceuticals Limited's earnings per share (EPS) in 2025?
In 2025, AFT Pharmaceuticals Limited's earnings per share (EPS) was $0.06, 33.33% less than in 2024 ($0.09).
How has AFT Pharmaceuticals Limited's earnings per share (EPS) changed since 2020?
From 2020 to 2025, AFT Pharmaceuticals Limited's earnings per share (EPS) went from $0.07 to $0.06, an average decline of 3.04% a year.
How does AFT Pharmaceuticals Limited's earnings per share (EPS) compare with similar companies?
AFT Pharmaceuticals Limited's earnings per share (EPS) ($0.08) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $6.50.